Rep. Roy Presses Biden Administration for Answers on Increased Restrictions for Monoclonal Antibody Treatments
September 14, 2021
September 14, 2021
WASHINGTON, Sept. 14 -- Rep. Chip Roy, R-Texas, issued the following news release on Sept. 13, 2021:
Congressman Chip Roy (TX-21) sent a letter to Health and Human Services (HHS) Secretary Xavier Becerra inquiring about recent changes to the process for doctors to obtain monoclonal antibody (mAb) treatments for COVID-19.
"As you know, antibody treatments such as bamlanivimab, bamlanivimab/etesevimab, and casirivimab/imdevimab were approved under Emergency Use Autho . . .
Congressman Chip Roy (TX-21) sent a letter to Health and Human Services (HHS) Secretary Xavier Becerra inquiring about recent changes to the process for doctors to obtain monoclonal antibody (mAb) treatments for COVID-19.
"As you know, antibody treatments such as bamlanivimab, bamlanivimab/etesevimab, and casirivimab/imdevimab were approved under Emergency Use Autho . . .